However, a recent study suggested that the predictive value of PD-L1 expression level was not significantly heterogeneity between squamous cell carcinoma and adenocarcinoma patients receiving ICIs plus chemotherapy (38). The gene discussed is CD274; the disease is squamous cell carcinoma.